People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Other Technology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kona Medical, Inc. | — | Biotechnology | Series B | $61.6M | $396.9M | 2010 |
| CV Ingenuity Corp. | — | Other Technology | Series B | $56.3M | $339.2M | 2009 |
| Amplitude Vascular Systems, Inc. | — | Software / Tech | Series B | $29.3M | $159.7M | 2020 |
Louis Cannon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Louis Cannon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ryan Drant | 1 | 24 |
| Peter Cohn | 1 | 10 |
| Duke Rohlen | 1 | 10 |
| Brian Halak | 1 | 10 |
| Robert Thomas | 1 | 8 |
| Henry A. Plain, Jr. | 1 | 7 |
| Douglas Koo | 1 | 7 |
| Justin Klein | 1 | 6 |
| Immanuel Thangaraj | 1 | 6 |
| David Long | 1 | 5 |
| Hank Plain | 1 | 5 |
| Allan Johnston | 1 | 3 |
| Christopher A. Shen | 1 | 3 |
| Bill Facteau | 1 | 2 |
| Justin T. Klein | 1 | 2 |
| Douglas T. Koo | 1 | 2 |
| Michael Gertner | 1 | 2 |
| William H. Kucheman | 1 | 2 |
| Mark Toland | 1 | 2 |
| Robert T. Thomas | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.